Perrigo Company
684 articles about Perrigo Company
-
Perrigo Company Authorizes Continuation Of Share Repurchase Program And Announces Quarterly Dividend
2/9/2007
-
Perrigo Company To Present At The Merrill Lynch Global Pharmaceutical, Biotechnology And Medical Device Conference
2/2/2007
-
Perrigo Company's Second Quarter Revenue Growth Driven By New Products
2/1/2007
-
Perrigo Company Will Release Second Quarter Fiscal 2007 Results On February 1, 2007
1/18/2007
-
Perrigo Company Announces FDA Approval For Simvastatin Tablets
12/21/2006
-
SCOLR Pharma, Inc. Partner Introduces Three New Products Based On SCOLR Technology
11/14/2006
-
Perrigo Company Announces Dividend Increase
11/10/2006
-
Perrigo Company Introduces Joe Papa As President And Chief Executive Officer On October 10, 2006
10/4/2006
-
Perrigo Company Receives Tentative Approval For Ciclopirox Topical Solution
10/3/2006
-
Perrigo Company Announces Approval For Famotidine Tablets
9/26/2006
-
Perrigo Company Announces Joseph C. Papa As New CEO; David T. Gibbons To Remain As Chairman
9/11/2006
-
Perrigo Company Receives Tentative Approval For Clobetasol Propionate Foam
9/1/2006
-
Perrigo Company Reports Fiscal Year 2006 Financial Results
8/9/2006
-
Perrigo Company To Market Terbinafine Hydrochloride Tablets
8/7/2006
-
Perrigo Company Will Release Fiscal Year 2006 Results On August 9, 2006
8/2/2006
-
Perrigo Company Announces Judy Brown Assumes CFO Position
7/7/2006
-
Perrigo Company To Market Amlodipine Besylate Tablets
6/30/2006
-
Perrigo Company To Close Two Plants, Sees $8 Million In Charges
6/27/2006
-
Perrigo Company Receives FDA Approval To Market Coated Nicotine Gum
6/14/2006
-
Perrigo Company Announces Participation In Dexcel Pharma's Filing For Generic Version Of Prilosec OTC(R)
6/7/2006